Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults

Cochrane Database of Systematic Reviews

Volumn 2000, Issue 4, 2000, Pages

  Tierney, Jayne F ^a,p   Alvegard T A ^b   Sigurdsson, H ^b   Antman, K ^c   Bacchi, M ^d   Baker, L H ^e   Benjamin, R S ^e   Brady, M F ^f   Bramwell, V ^g   Bui, B N ^h   Edmonson, J H ⁱ   Fletcher, C D M ^j   Gherlinzoni, F ^k   Jones, G ^l   Patel, M ^l   Leyvraz, S ^m   Mosseri, V ⁿ   Omura, G A ^o   Parmar, M K B ^p   Stewart, L A ^p   Rouesse J ^q   Ruiz de Elvira, M C ^a   Ryan, L ^r   Souhami, R L ^s   Sylvester, R ^t   Tursz, T ^u   van Oosterom, A T ^v   Yang, J C ^w   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d SIAK Coordinating Center   (Switzerland)

^e UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g CHRISTIE HOSPITAL   (United Kingdom)

^h INSTITUT BERGONIÉ   (France)

ⁱ MAYO CLINIC   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^l JURAVINSKI CANCER CENTRE   (Canada)

^m LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁿ INSTITUT CURIE   (France)

^o UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^p MEDICAL RESEARCH COUNCIL   (United Kingdom)

^q CENTRE RENÉ HUGUENIN   (France)

^r DANA FARBER CANCER INSTITUTE   (United States)

^s UNIVERSITY COLLEGE LONDON   (United Kingdom)

^t EORTC DATA CENTER   (Belgium)

^u INSTITUT GUSTAVE ROUSSY   (France)

^v UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^w NATIONAL CANCER INSTITUTE   (United States)

^x Universitaire Ziekenhuizen ^*  (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN;

ADJUVANT THERAPY; AGE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DRUG EFFECT; FOLLOW UP; GENDER; HISTOPATHOLOGY; HUMAN; LIMB; LOCAL RECURRENCE FREE SURVIVAL; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; REVIEW; RISK BENEFIT ANALYSIS; SOFT TISSUE SARCOMA; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREND STUDY; ADJUVANT CHEMOTHERAPY; ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SARCOMA;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DOXORUBICIN; HUMANS; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS; SARCOMA;

EID: 34548144593     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001419     Document Type: Review

References (47)

1. Ravaud A, Bui BB, Coindre J-M, Kantor G, Stöckle E, Lagarde P, et al.Adjuvant chemotherapy with cyvadic in high risk soft tissue sarcoma: a randomised prospective trial. In: Salmon SE editor(s). Adjuvant therapy of cancer VI. Philadelphia: Saunders, W.B., 1990:556-66.
2. Antman K, Suit H, Amato D, Corson J, Wood W, Proppe K, et al.Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups. Journal of Clinical Oncology 1984;2(6):601-8.
3. Lerner HJ, Amato DA, Savlov ED, DeWys WD, Mittelman A, Urtasun RC, et al.Eastern Cooperative Oncology Group: A comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma. Journal of Clinical Oncology 1987;5(4):613-7.
4. Bramwell V, Rouesse J, Steward W, Santoro A, Schraffordt-Koops H, Buesa J, et al.Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma - reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Journal of Clinical Oncology 1994;12(6):1137-49.
5. Omura GA, Blessing JA, Major F, Liftshitz S, Ehrlich CE, Mangan C, et al.A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. Journal of Clinical Oncology 1985;3(9):1240-5.
6. Antman K, Ryan L, Borden E, Wood WC, Lerner HJ, Corson JM, et al.Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results and review of the literature. In: Salmon SE editor(s). Adjuvant therapy of cancer VII. Philadelphia: W.B. Saunders, 1990:529-43.
7. Baker LH. Adjuvant therapy for soft tissue sarcomas. In: Ryan JR, Baker LH editor(s). Recent Concepts in Sarcoma Treatment. Dordecht: Kluwer Academic Publishers, 1988:130-5.
8. Edmonson JH. Systemic chemotherapy following complete excision of nonosseous sarcomas: Mayo Clinic Experience. Cancer Treatment Symposia 1985;3:89-97.
9. Edmonson JH, Fleming TR, Ivins JC, Burgert EO, Jr, Soule EH, O'Connell MJ, et al.Randomized study of systemic chemotherapy following complere excision of nonosseous sarcomas. Journal of Clinical Oncology 1984;2(12):1390-6.
10. Benjamin RS, Terjanian TO, Fenoglio CJ, Barkley HT, Evans HL, Murphy WK, et al.The importance of combination chemotherapy for adjuvant treatment of high-risk patients with soft-tissue sarcomas of the extremities. In: Salmon SE editor(s). Adjuvant therapy of cancer V. Orlando: Grune & Stratton, 1987:735-44.
11. Chang AE, Kinsella T, Glatstein E, Baker AR, Sindelar WF, Lotze MT, et al.Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. Journal of Clinical Oncology 1988;6(9):1491-500.
12. Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, et al.Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer 1983;52:424-34.
13. Glenn J, Kinsella T, Glatstein E, Tepper J, Baker A, Sugarbaker P, et al.A randomized prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk. Cancer 1985;55:1206-14.
14. Glenn J, Sindelar WF, Kinsella T, Glatstein E, Tepper J, Gosta J, et al.Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery 1985;97(3):316-25.
15. Chang AE, Kinsella T, Glatstein E, Baker AR, Sindelar WF, Lotze MT, et al.Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. Journal of Clinical Oncology 1988;6(9):1491-500.
16. Rosenberg SA, Tepper J, Glatstein E, et al.Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer 1983;52:424-34.
17. Gherlinzoni F, Bacci G, Picci P, Capanna R, Calderoni P, Lorenzi EG, et al.A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. Journal of Clinical Oncology 1986;4(4):552-8.
18. Picci P, Bacci G, Gherlinzoni F, Capanna R, Mercuri M, Ruggieri P, et al.Results of a randomised trial for the treatment of localized soft tissue tumors (STS) of the extremities in adult patients. In: Ryan JR, Baker LH editor(s). Recent Concepts in Sarcoma Treatment. Dordecht: Kluwer Academic Publishers, 1988:144-8.
19. SAKK. Randomized study of adjuvant chemotherapy with adriamycin and ifosfamide versus observation in patients with soft-tissue sarcomas of extremity and trunk. Data on file Unpublished.
20. Alvegård TA, Sigurdsson H, Mouridsen H, Solheim Ø, Unsgaard B, Ringborg U, et al.Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. Journal of Clinical Oncology 1989;7(10):1504-13.
21. Baker LH, Franks J, Fine G, Balcerzak SP, Stephens RL, Stuckey WJ, et al.Combination chemotherapy using Adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomised comparative trial, A phase III, Southwest Oncology Group Study. Journal of Clinical Oncology 1987;5(6):851-61.
22. Borden EC, Amato DA, Edmonson JH, Ritch PS, Shiraki M. Randomized comparison of doxorubicin and vindesinme to doxorubicin for patients with metastatic soft-tissue sarcomas. Cancer 1990;66:862-7.
23. Eilber FR, Giuliano AE, Huth JF, Morton DL. A randomised prospective trial using postoperative adjuvant chemotherapy (Adriamycin) in high-grade extremity soft-tissue sarcoma. American Journal of Clinical Oncology 1988;11(1):39-45.
24. IGSC. A randomized trial of adjuvant doxorubicin (Adriamycin) versus standard therapy (a delay of chemotherapy until the time of possible relapse. Data on file Unpublished.
25. Frustaci S, Gherlinzoni F, De Paoli A, Pignatti G, Zmerly H, Azzarelli A, Comandone A, Buonadonna A, Olmi P, Ippolito V, Barbieri E, Apice G, Zakotnic B, Bacci G, Picci P, on behalf of the National Research Council (Italy). Preliminary results of an adjuvant randomized trial on high risk extremity soft tissue sarcomas (STS). The interim analysis. Proceedings of the American Society of Clinical Oncology. 1997; Vol. 16:696a, A1785.
26. Kinsella T, Sindelar W, Lack E, Glatstein E, Rosenberg SA. Kinsella T, Sindelar W, Lack E, Glatstein E, Rosenberg SA. Journal of Clinical Oncology 1988;6:18-25.
27. NCI. Phase III randomized trial of adjuvant DOX/IFF vs no adjuvant chemotherapy following complete resection of adult high-grade soft tissue sarcoma confined to an extremity. Data on file Unpublished.
28. Pinedo HM, Verweij J. The treatment of soft tissue sarcomas with focus on chemotherapy: a review. Radiotherapeutic Oncology 1986;5:193-205.
29. Piver MS, Lele SB, Marchetti DL, Emrich LJ. Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas. Journal of Surgical Oncology 1988;38:233-9.
30. Schoenfeld DA, Roesenbaum C, Horton J, Wolter JM, Falkson G, DeConti RC. A comparison of Adriamycin versus Vincristine and Adraimycin, and Cyclosphosphamide versus Vincristine, Actinomycin-D, and Cyclophosphamide for advanced sarcoma. Cancer 1982;50:2757-62.
31. SWOG. Phase III randomized study of adjuvant chemotherapy with ADR/DTIC/IPP vs no adjuvant therapy following resection with or without irradiation of adult grage III soft tissue sarcomas. Data on file Unpublished.
32. Phase II randomized study of adjuvant high-dose DOX/IFF with G-CSFvs no adjuvant chemotherapy for high-grade soft tissue sarcoma. Ongoing study Starting date of trial not provided. Contact author for more information.
33. Benjamin R, Weirnick P, Bachur N. Adriamycin: a new effective agent in the therapy of disseminated sarcomas. Medical and Pediatric Oncology 1975;1:63-76.
34. Blum RH, Carter SK. A new anticancer drug with significant clinical activity. Annals of Internal Medicine 1974;80(2):249-59.
35. Collins R, Gray R, Godwin J, Peto R. Avoidance of large biases and large random errors in the assessment of moderate effects of treatment effects: the need for systematic overviews. Statistics in Medicine 1987;6:245-50.
36. Delaney TF, Yang JC, Glatstein E. Adjuvant therapy for adult patients with soft tissue sarcomas. Oncology 1991;5(6):105-18.
37. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. In: Chalmers I, Altman DG editor(s). Systematic Reviews. London: BMJ Publishing Group, 1995:17-36.
38. Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Statistics in Medicine 1982;1:121-9.
39. Gottlieb JA, Baker LH, O'Bryan RM, Sinkovics JG, Hoogstraten B, Quagliana JM, et al.Adriamycin (NSC-123127) used alone and in combination for soft tissue and bony sarcomas. Cancer Chemotherapy Reports Part 3 1975;6(2):271-82.
40. Jones GW, Chouinard M, Patel M. Adjuvant adriamycin (doxorubicin) in adult patients with soft-tissue sarcomas: A systematic overview and quantitative meta-analysis. Clinical Investigations in Medicine 1994;14 Suppl 19:A772.
41. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. Journal of the American Statistical Association 1958;53:457-81.
42. McGrath PC, Sloan DA, Kenady DE. Adjuvant therapy of soft-tissue sarcomas. Clinics in Plastic Surgery 1995;22(1):21-9.
43. Mertens WC, Bramwell VHC. Adjuvant chemotherapy for soft tissue sarcomas. Hematology/Oncology Clinics of North America 1995;9(4):801-15.
44. Tierney JF, Mosseri V, Stewart LA, Souhami RL, Parmar MKB. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. British Journal of Cancer 1995;72:469-75.
45. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: An overview of the randomised trials. Progress in Cardiovascular Diseases 1985;27(5):335-71.
46. Zalupski MM, Ryan JR, Hussein ME, Baker LH. Defining the role of adjuvant chemotherapy for patients with soft tissue sarcoma of the extremities. In: Salmon SE editor(s). Adjuvant Therapy of Cancer VII. Philadelphia: JB Lippincott Company, 1993:385-92.
47. Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. The Lancet 1997;350:1647-54.